Clinical Practice Guidelines
EHA creates clinical practice guidelines for diagnosis and treatment of hematologic diseases. This initiative started in 2019 with the establishment of a Guidelines Committee and the definition the EHA Methodology for guidelines. Since then, in addition to developing its own guidelines, EHA has established a framework for collaboration with ESMO (European Society for Medical Oncology) to produce guidelines on hematologic malignancies.
The Guidelines Committee has approved the following methodology documents:
For guidance regarding COVID-19, see FAQ by the EHA SWG on Infections
EHA has also initiated a series of online workshops dedicated to guidelines (produced or endorsed by EHA) for diagnosis and treatment of hematologic diseases. These workshops, which will begin in November 2020, are aimed at disseminating good practices and knowledge with the help of patient cases, presentations and discussions with the guidelines’ authors and EHA experts.